IP Library › Granted Patent US 7,282,591
Granted Patent B2
US 7,282,591 · App. 10/508,897 · Granted Oct 16, 2007

1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,282,591
App. No.
10/508,897
Granted
Oct 16, 2007
Kind
B2
Abstract

The present invention encompasses compounds of Formula I: (I) or pharmaceutically acceptable salts or hydrates thereof, which are useful as selective glucocorticoid receptor ligands for treating a variety of autoimmune and inflammatory diseases or conditions. Pharamaceutical compositions and methods of use are also included.

Claims (4)

1. A compound which is:

or a pharmaceutically acceptable salt thereof.

2. A compound selected from the following group:

or a pharmaceutically acceptable salt of any of the foregoing compounds.

Assignments (2)
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2007
From: ALI, AMJAD; BALKOVEC, JAMES M.; GRAHAM, DONALD W.; THOMPSON, CHRISTOPHER F.; QURAISHI, NAZIA
To: MERCK & CO., INC.
Reel/Frame 019636/0133 →